Recent Update on the Pharmacological Effects and Mechanisms of Dihydromyricetin
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
As the most abundant natural flavonoid in rattan tea, dihydromyricetin (DMY) has shown a wide range of pharmacological effects. In addition to the general characteristics of flavonoids, DMY has the effects of cardioprotection, anti-diabetes, hepatoprotection, neuroprotection, anti-tumor, and dermatoprotection. DMY was also applied for the treatment of bacterial infection, osteoporosis, asthma, kidney injury, nephrotoxicity and so on. These effects to some extent enrich the understanding about the role of DMY in disease prevention and therapy. However, to date, we still have no outlined knowledge about the detailed mechanism of DMY, which might be related to anti-oxidation and anti-inflammation. And the detailed mechanisms may be associated with several different molecules involved in cellular apoptosis, oxidative stress, and inflammation, such as AMP-activated protein kinase (AMPK), mitogen-activated protein kinase (MAPK), protein kinase B (Akt), nuclear factor-κB (NF-κB), nuclear factor E2-related factor 2 (Nrf2), ATP-binding cassette transporter A1 (ABCA1), peroxisome proliferator-activated receptor-γ (PPARγ) and so on. Here, we summarized the current pharmacological developments of DMY as well as possible mechanisms, aiming to push the understanding about the protective role of DMY as well as its preclinical assessment of novel application.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Polyphenols and bioavailability: an update
Teng, H., & Chen, L. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1437023 · Cited by 336 · cited 1×
“Many experiments found that polyphenolics had low oral bioavailability (Teng and Chen, 2018).”
BackgroundChen, L., Teng, H., Xie, Z., Cao, H., Cheang, W. S., Skalicka-Woniak, K., Georgiev, M. I., & Xiao, J. (2018) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2016.1196334 · Cited by 291
Adriamycin cardiotoxicity: a survey of 1273 patients.
Praga, C., Beretta, G., Pl, V., Gr, L., Pollini, C., Bonadonna, G., Canetta, R. M., Castellani, R., Villa, E., Cg, G., et al. (1979) · PubMed · Cited by 248
Chen, S., Zhao, X., Wan, J., Ran, L., Qin, Y., Wang, X., Gao, Y., Shu, F., Zhang, Y., Liu, P., et al. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.05.009 · Cited by 235
Dihydromyricetin As a Novel Anti-Alcohol Intoxication Medication
Shen, Y., Lindemeyer, A. K., Gonzalez, C., Shao, X. M., Spigelman, I., Olsen, R. W., & Liang, J. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.4639-11.2012 · Cited by 213
Hu, Q., Zhang, T., Yi, L., Zhou, X., & Mi, M. (2018) · BioFactors · doi:10.1002/biof.1395 · Cited by 180
Zeng, X., Yang, J., Hu, O., Huang, J., Ran, L., Chen, M., Zhang, Y., Zhou, X., Zhu, J., Zhang, Q., et al. (2019) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7172 · Cited by 163
Wu, Y., Bai, J., Zhong, K., Huang, Y., & Gao, H. (2016) · Food Chemistry · doi:10.1016/j.foodchem.2016.07.090 · Cited by 160
Meng, G., Liu, J., Liu, S., Song, Q., Liu, L., Xie, L., Han, Y., & Ji, Y. H. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13861 · Cited by 126
Self-citationHou, X., Tong, Q., Wang, W., Xiong, W., Shi, C., & Fang, J. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.03.007 · Cited by 115
Cited by
Chang, Y., Yuan, L., Liu, J., Muhammad, I., Cao, C., Shi, C., Zhang, Y., Li, R., Li, C., & Liu, F. (2020) · Veterinary Research · doi:10.1186/s13567-020-00796-8 · Cited by 74
Metadata
- Authors
- Zhang, J., Chen, Y., Luo, H., Sun, L., Xu, M., Yu, J., Zhou, Q., Meng, G., & Yang, S.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2018-10-25
- Volume
- 9
- Pages
- 1204-1204
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W2898097157
- Cited by
- 207
- References
- 56
- FWCI
- 16.73
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.